Revaccination at 12 months with the investigational respiratory syncytial virus (RSV) vaccine mRNA-1345 is well tolerated and supported for eligible older adults, according to study results presented ...

Poll Finds Public Fears Over RSV Have Eased, Although It Remains a Threat By Dennis Thompson HealthDay Reporter WEDNESDAY, Oct. 16, 2024 (HealthDay News) -- Public concerns about contracting RSV ...

Polymerase-chain-reaction (PCR) testing of a nasopharyngeal sample was negative for severe acute respiratory syndrome coronavirus 2, influenza virus, and respiratory syncytial virus (RSV); rapid ...

BUT HOW DO YOU KNOW IF IT’S THE FLU, RSV OR COVID? TO HELP YOU UNDERSTAND THE DIFFERENCE, THIS MORNING WE WELCOME DOCTOR VANESSA WALKER WITH SUTTER HEALTH. THANK YOU SO MUCH FOR BEING HERE.

RSV is a virus that can make people sick, especially older adults and babies. But even though RSV can be serious, people aren't as worried about it anymore. RSV is common but can be dangerous ...

Oct. 18, 2024 – Older people who aren’t sure about whether to get the vaccine for respiratory syncytial virus (RSV) now have a new set of data to help them make up their minds. A large study ...

RSV vaccines hold the potential to reduce the thousands of hospitalizations and deaths associated with the virus in the US each year. But vaccines are only effective if they get in the arms of the ...

Rates of SUID per 100,000 live births rose by 10% from 2019 to 2021. A rise in rates of sudden unexpected infant deaths may have been linked to an off-season surge of respiratory syncytial virus ...

A global real-world study of the vaccine for respiratory syncytial virus (RSV) finds it offers folks aged 60 and over 80% protection against severe illness and/or hospitalization. With U.S ...

The time for the cold-weather spread of COVID-19, influenza and respiratory syncytial virus (RSV) is quickly approaching. With it comes a new wave of illnesses that can result in school absences ...

Cold and flu season — otherwise known as mid-October — is upon us. But this year, several advancements in vaccines could help families keep viruses at bay. One of the new developments is a ...

Ziresovir reduces respiratory syncytial virus (RSV) symptoms and viral load in infants ... elevated liver enzyme levels, and rash. Notably, 9% of participants in the ziresovir group developed ...